Insider · CIK 0001786386
Justin J. McAnear
Files at ALMR (Alamar Biosciences, Inc.). First filing -, latest -.
Justin J. McAnear files SEC Form 4 as CFO at ALMR (Alamar Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Justin J. McAnear has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | AGrant or award Common Stock | +37,220 | $0.00 | $0 | 37,220 | Apr 20, 2026 |
| Apr 16, 2026 | ALMR Alamar Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +163,358 | $0.00 | $0 | 163,358 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -570,719 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | +570,719 | $0.00 | $0 | 570,719 | Apr 20, 2026 |
Questions about Justin J. McAnear
Answered from the filings on this page, as of the latest one.
Is Justin J. McAnear buying or selling?
Justin J. McAnear has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Justin J. McAnear's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Justin J. McAnear has 0.
Where does Justin J. McAnear file Form 4?
Justin J. McAnear has filed Form 4 at ALMR (Alamar Biosciences, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.